Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
about
FTO: the first gene contributing to common forms of human obesityType 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1)Muscle atrophy in transgenic mice expressing a human TSC1 transgeneThe Aryl Hydrocarbon Receptor Relays Metabolic Signals to Promote Cellular RegenerationPost-transcriptional regulation in metabolic diseasesInsulin-like growth factor-1 deficiency and metabolic syndromeRole of IGF-I signaling in muscle bone interactionsMitochondrial regulation of β-cell function: maintaining the momentum for insulin releaseRegulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2Effects of mutations in the insulin-like growth factor signaling system on embryonic pancreas development and beta-cell compensation to insulin resistanceMetformin Improves Diabetic Bone Health by Re-Balancing Catabolism and Nitrogen DisposalRole of insulin-like growth factor-binding protein 5 (IGFBP5) in organismal and pancreatic beta-cell growthPPARs and the complex journey to obesityInsulin signaling regulates mitochondrial function in pancreatic beta-cellsRole of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action.Diabetic nephropathy in a nonobese mouse model of type 2 diabetes mellitus.Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.Molecular and metabolic evidence for mitochondrial defects associated with beta-cell dysfunction in a mouse model of type 2 diabetesInsulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression.Succinate and its G-protein-coupled receptor stimulates osteoclastogenesis.Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action.Insulin-like growth factor 1-mediated hyperthermia involves anterior hypothalamic insulin receptors.Intracerebroventricular leptin infusion improves glucose homeostasis in lean type 2 diabetic MKR mice via hepatic vagal and non-vagal mechanisms.Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus.Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes.The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes.Multi-tissue computational modeling analyzes pathophysiology of type 2 diabetes in MKR mice.IGF1 Shapes Macrophage Activation in Response to Immunometabolic Challenge.High-frequency electrically stimulated skeletal muscle contractions increase p70s6k phosphorylation independent of known IGF-I sensitive signaling pathwaysInsulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetesThe proliferating role of insulin and insulin-like growth factors in cancer.Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic conditionMulti-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats.Two tales of antioxidant enzymes on β cells and diabetes.Anti-Inflammatory Action of Insulin via Induction of Gadd45-β Transcription by the mTOR Signaling Pathway.Mouse models of insulin resistance.Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy.Insulin resistance and pancreatic beta cell failureKnockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance.Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle
P2860
Q22242403-AB3149D1-FAA2-4DE1-9C0E-0A0295ECF932Q24293531-305D7510-F7E5-4360-AB5C-C0027BE3A37DQ24304304-C34557AA-5537-435D-A720-D03D84C519D2Q26738807-34BC9A60-7744-4C63-88BF-B2BDF3E933D6Q27028039-181CC5D0-E03D-41B8-8990-6650195F91D6Q28072410-5ABF6B0F-7BDC-4239-919F-4A26E85C937FQ28082188-552099AE-2C89-44AE-A8CF-574E8A4E5378Q28083598-89BEDA5D-96C7-441D-B534-FE057540BCFDQ28272571-2A88A12C-227C-4B2C-A71F-4DE380EE1632Q28512935-55E26038-D341-4C69-A7FA-15394E7E5D8DQ28551882-1DFD3887-7A54-48E2-B8EF-44F3ACFF99B6Q28587246-AB6757F5-7ADB-47FE-8BC2-DFC26CF299ADQ29619271-2E9B9124-BB4B-4148-97B5-6908E73387A0Q30945275-B3E64E8C-08C1-441F-A745-F261DFD1FEC5Q33305207-9A9F03DC-5784-4005-B975-5DEEE04CA76BQ33568898-29E7780B-6726-4226-8AAA-F7040D35A382Q33569425-F63BC562-21DF-42B9-B3BA-302C76D5575FQ33604502-80587730-C320-4622-950A-4D94F2A01844Q33688576-32F6E324-57EF-424A-9377-77F1D622C957Q33766770-8177E150-49B4-4645-A3C4-1B895C3F1A69Q33768316-2E621E3A-0FD3-468D-B516-612FA846DF19Q33823428-2C8E7B53-7DB4-445B-865B-5875A9193EFAQ33838408-6050C6E7-34FB-4C01-AE0F-DF0A72CBFB34Q33846064-64D5D76B-4319-45A2-8938-7D40DD8D3430Q33849666-1B9E0BB0-DCA9-45EF-B3A0-AEF130CB014DQ33867998-5DF2BF78-7D69-4B32-BE36-0811EAB5B4CDQ33910761-5DFA8B84-AD81-48C4-A302-C4EFD780D906Q33910916-0E891C3C-90DB-49EE-A172-39CF833B4066Q33961585-D6A830B4-240D-4720-8E59-DE47B3B9F6C0Q34157626-2B4CE834-3011-42FD-9CCC-2BA505172EF6Q34172625-FD4F5FC5-3A71-463D-AA9C-2A8FF70A3625Q34337315-F69E1FED-B56B-4334-A021-9C3922CE2C50Q34501727-9216E8F5-3F71-4FCA-B5DD-CC1E06D1A628Q34519495-32F45510-A29C-41D4-97AD-557F2EC371FCQ34535791-F6BAFFA3-404F-46A9-989D-04E1E195E0DBQ34588917-24725FE9-541E-4B70-BBC2-4E91521CE308Q34691744-F94ECB71-9367-486C-A1AF-F18F488F1EE0Q34698828-3290F10A-C74F-4D38-901E-5865521A2369Q34722653-03BC3A4C-83EE-4DB3-B0E5-72F3F62A525FQ34787562-490BD8CF-4642-4FF6-9907-1EF0E6BE593F
P2860
Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Functional inactivation of the ...... muscle causes type 2 diabetes
@ast
Functional inactivation of the ...... muscle causes type 2 diabetes
@en
Functional inactivation of the ...... muscle causes type 2 diabetes
@nl
type
label
Functional inactivation of the ...... muscle causes type 2 diabetes
@ast
Functional inactivation of the ...... muscle causes type 2 diabetes
@en
Functional inactivation of the ...... muscle causes type 2 diabetes
@nl
prefLabel
Functional inactivation of the ...... muscle causes type 2 diabetes
@ast
Functional inactivation of the ...... muscle causes type 2 diabetes
@en
Functional inactivation of the ...... muscle causes type 2 diabetes
@nl
P2093
P2860
P3181
P356
P1433
P1476
Functional inactivation of the ...... muscle causes type 2 diabetes
@en
P2093
A L Castle
A M Fernández
C Hernandez-Sanchez
D Le Roith
G I Shulman
P2860
P304
P3181
P356
10.1101/GAD.908001
P407
P577
2001-08-01T00:00:00Z